Clinical Trial Update: Bevacizumab Versus Mitomycin C as Trabeculectomy Adjuvant in Uncontrolled Glaucoma [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial comparing bevacizumab to mitomycin C as adjuvants during trabeculectomy for uncontrolled glaucoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• Mitomycin-C (mitomycin C)

Snippet

Sponsor: Athens Vision Eye Institute | Conditions: Glaucoma | Phase 2, Phase 3 | Status: COMPLETED